A Study of Epacadostat (INCB024360) in Combination With Durvalumab (MEDI4736) in Subjects With Selected Advanced Solid Tumors (ECHO-203)

Clinical trial NCT02318277 · COMPLETED

Trial details

NCT number: NCT02318277
Sponsor: Incyte Corporation
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumors Head and Neck Cancer Lung Cancer UC (Urothelial Cancer)

Start date: 2015-01-05
Primary completion: 2019-08-28
Enrollment: 176

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.